The Role of CCNs in Controlling Cellular Communication in the Tumor Microenvironment

Overview

Journal J Cell Commun Signal

Date 2022 Jun 8

PMID 35674933

Authors

Lauren B Birkeness

Snigdha Banerjee

Mohiuddin Quadir

Sushanta K Banerjee

Affiliations

Soon will be listed here.

Abstract

The Cellular communication network (CCN) family of growth regulatory factors comprises six secreted matricellular proteins that promote signal transduction through cell-cell or cell-matrix interaction. The diversity of functionality between each protein is specific to the many aspects of healthy and cancer biology. For example, CCN family proteins modulate cell adhesion, proliferation, migration, invasiveness, apoptosis, and survival. In addition, the expression of each protein regulates many biological and pathobiological processes within its microenvironment to regulate angiogenesis, inflammatory response, chondrogenesis, fibrosis, and mitochondrial integrity. The collective range of CCN operation remains fully comprehended; however, understanding each protein's microenvironment may draw more conclusions about the abundance of interactions and signaling cascades occurring within such issues. This review observes and distinguishes the various roles a CCN protein may execute within distinct tumor microenvironments and the biological associations among them. Finally. We also review how CCN-family proteins can be used in nano-based therapeutic implications.

Citing Articles

WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.

Christopoulou M, Aletras A, Papakonstantinou E, Stolz D, Skandalis S Int J Mol Sci. 2024; 25(18).

PMID: 39337534 PMC: 11432718. DOI: 10.3390/ijms251810049.

Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice.

Tejera-Munoz A, Cortes M, Rodriguez-Rodriguez A, Tejedor-Santamaria L, Marchant V, Rayego-Mateos S Int J Mol Sci. 2024; 25(17).

PMID: 39273564 PMC: 11394698. DOI: 10.3390/ijms25179617.

The role of yes activated protein (YAP) in melanoma metastasis.

Leask A, Nguyen J, Naik A, Chitturi P, Riser B iScience. 2024; 27(6):109864.

PMID: 38770136 PMC: 11103372. DOI: 10.1016/j.isci.2024.109864.

Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.

Banerjee S, Ansari A, Upadhyay S, Mettman D, Hibdon J, Quadir M Cells. 2024; 13(5.

PMID: 38474359 PMC: 10930662. DOI: 10.3390/cells13050395.

Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis.

Hutchenreuther J, Nguyen J, Quesnel K, Vincent K, Petitjean L, Bourgeois S Cancer Res Commun. 2024; 4(2):556-570.

PMID: 38363129 PMC: 10898341. DOI: 10.1158/2767-9764.CRC-23-0571.

References

Ahmed K, Hasib T, Paul S, Saddam M, Mimi A, Saikat A . Potential Role of CCN Proteins in Breast Cancer: Therapeutic Advances and Perspectives. Curr Oncol. 2021; 28(6):4972-4985. PMC: 8700172. DOI: 10.3390/curroncol28060417. View

Babic A, Kireeva M, Kolesnikova T, Lau L . CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A. 1998; 95(11):6355-60. PMC: 27701. DOI: 10.1073/pnas.95.11.6355. View

Baguma-Nibasheka M, Kablar B . Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse. Dev Dyn. 2008; 237(2):485-93. DOI: 10.1002/dvdy.21433. View

Banerjee S, Banerjee S . CCN5/WISP-2: A micromanager of breast cancer progression. J Cell Commun Signal. 2012; 6(2):63-71. PMC: 3368018. DOI: 10.1007/s12079-012-0158-2. View

Banerjee S, Dhar G, Haque I, Kambhampati S, Mehta S, Sengupta K . CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res. 2008; 68(18):7606-12. DOI: 10.1158/0008-5472.CAN-08-1461. View

Banerjee S, Ghosh A, VonHoff D, Banerjee S . Cyr61/CCN1 targets for chemosensitization in pancreatic cancer. Oncotarget. 2019; 10(38):3579-3580. PMC: 6557211. DOI: 10.18632/oncotarget.26986. View

Banerjee S, Maity G, Haque I, Ghosh A, Sarkar S, Gupta V . Human pancreatic cancer progression: an anarchy among CCN-siblings. J Cell Commun Signal. 2016; 10(3):207-216. PMC: 5055500. DOI: 10.1007/s12079-016-0343-9. View

Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo M, Banerjee S . WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia. 2003; 5(1):63-73. PMC: 1502127. DOI: 10.1016/s1476-5586(03)80018-0. View

Benini S, Perbal B, Zambelli D, Colombo M, Manara M, Serra M . In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene. 2005; 24(27):4349-61. DOI: 10.1038/sj.onc.1208620. View

10.

Brown B, Connolly G, Mill C, Williams H, Angelini G, Johnson J . Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells. Aging Cell. 2018; 18(1):e12844. PMC: 6351844. DOI: 10.1111/acel.12844. View

11.

Bussard K, Mutkus L, Stumpf K, Gomez-Manzano C, Marini F . Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016; 18(1):84. PMC: 4982339. DOI: 10.1186/s13058-016-0740-2. View

12.

Chen P, Cheng H, Yang S, Lin C, Tang C . The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors. Biomed Res Int. 2014; 2014:437096. PMC: 3914550. DOI: 10.1155/2014/437096. View

13.

Chen R, Masuo K, Yogo A, Yokoyama S, Sugiyama A, Seno H . SNAIL regulates gastric carcinogenesis through CCN3 and NEFL. Carcinogenesis. 2020; 42(2):190-201. DOI: 10.1093/carcin/bgaa133. View

14.

Delmolino L, Stearns N, Castellot Jr J . COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol. 2001; 188(1):45-55. DOI: 10.1002/jcp.1100. View

15.

Dhar K, Banerjee S, Dhar G, Sengupta K, Banerjee S . Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells. Cancer Res. 2007; 67(4):1520-6. DOI: 10.1158/0008-5472.CAN-06-3753. View

16.

Dhar G, Banerjee S, Dhar K, Tawfik O, Mayo M, VanVeldhuizen P . Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2. Cancer Res. 2008; 68(12):4580-7. DOI: 10.1158/0008-5472.CAN-08-0316. View

17.

Dhar G, Mehta S, Banerjee S, Gardner A, McCarty B, Mathur S . Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Cancer Lett. 2007; 254(1):63-70. DOI: 10.1016/j.canlet.2007.02.012. View

18.

Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

19.

Gascard P, Tlsty T . Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016; 30(9):1002-19. PMC: 4863733. DOI: 10.1101/gad.279737.116. View

20.

Giusti V, Scotlandi K . CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology. J Cell Commun Signal. 2021; 15(4):545-566. PMC: 8642527. DOI: 10.1007/s12079-021-00631-5. View